tiprankstipranks
Shandong Weigao Group Medical Polymer Co Ltd Class H (SHWGF)
OTHER OTC:SHWGF

Shandong Weigao Group Medical Polymer Co (SHWGF) Income Statement

11 Followers

Shandong Weigao Group Medical Polymer Co Income Statement

Last quarter (Q2 2022), Shandong Weigao Group Medical Polymer Co's total revenue was ¥―, a decrease of ― from the same quarter last year. In Q2, Shandong Weigao Group Medical Polymer Co's net income was ¥―. See Shandong Weigao Group Medical Polymer Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-¥ 13.15B¥ 11.35B¥ 10.38B¥ 8.81B¥ 6.29B
Cost of Revenue
-¥ 5.88B¥ 4.89B¥ 3.87B¥ 3.42B¥ 2.30B
Gross Profit
-¥ 7.27B¥ 6.46B¥ 6.51B¥ 5.39B¥ 3.99B
Operating Expense
-¥ 4.15B¥ 3.97B¥ 4.08B¥ 3.67B¥ 2.64B
Operating Income
-¥ 3.12B¥ 2.49B¥ 2.44B¥ 1.72B¥ 1.36B
Net Non Operating Interest Income Expense
-¥ 3.55M¥ -64.69M¥ -268.60M¥ -113.60M¥ 48.35M
Other Income Expense
------
Pretax Income
-¥ 2.84B¥ 2.50B¥ 2.25B¥ 1.78B¥ 1.53B
Tax Provision
-¥ 415.09M¥ 345.64M¥ 327.14M¥ 258.43M¥ 224.40M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-¥ 2.24B¥ 2.03B¥ 1.85B¥ 1.47B¥ 1.73B
Basic EPS
--¥ 0.45¥ 0.41¥ 0.33¥ 0.39
Diluted EPS
--¥ 0.45¥ 0.41¥ 0.33¥ 0.39
Basic Average Shares
--¥ 4.49B¥ 4.48B¥ 4.48B¥ 4.48B
Diluted Average Shares
--¥ 4.49B¥ 4.48B¥ 4.48B¥ 4.48B
Dividend Per Share
--¥ 0.12¥ 0.11¥ 0.00¥ 0.09
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-¥ 10.03B¥ 8.85B¥ 7.95B¥ 7.09B¥ 4.94B
Net Income From Continuing And Discontinued Operation
-¥ 2.24B¥ 2.03B¥ 1.85B¥ 1.47B¥ 1.73B
Normalized Income
-¥ 2.53B¥ 1.97B¥ 1.91B¥ 1.48B¥ 1.20B
Interest Expense
-¥ 140.40M¥ 178.94M¥ 397.95M¥ 284.41M¥ 23.89M
EBIT
-¥ 2.98B¥ 2.67B¥ 2.65B¥ 2.06B¥ 1.55B
EBITDA
-¥ 3.71B¥ 3.37B¥ 3.27B¥ 2.62B¥ 1.91B
Currency in CNY

Shandong Weigao Group Medical Polymer Co Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis